Skip to main content

Pa. Jury's First Risperdal Punitive Damages Trial Begins

Pa. Jury's First Risperdal Punitive Damages Trial Begins

Pa. Jury's First Risperdal Punitive Damages Trial Begins

Introduction

A Risperdal punitive damages trial commenced last week in Philadelphia against Johnson & Johnson’s (J&J) subsidiary Janssen Pharmaceuticals for illegally marketing drugs for off-label use in children. The trial is considered to be the first by a Pennsylvania jury to consider awarding punitive damages in a Risperdal case.

The lawsuit involves a plaintiff, who won $1.75 million in 2015, which was later reduced to $685,000, over claims against the pharmaceutical giant for causing his gynecomastia, an undesired growth of breast tissue in males after using Risperdal. The plaintiff started taking the powerful antipsychotic drug in 2003, at the time when the U.S. Food & Drug Administration (FDA) had not approved the drug for use in children. Following the New Jersey law, the Philadelphia judge barred Risperdal plaintiffs from seeking punitive damages in the litigation. The rule was later reversed by the Pennsylvania Superior Court, stating that, each plaintiff could apply the law of their home state on the punitive damages issue.

The stakes for the mass tort, which has around 7,000 cases pending in Philadelphia along with several multimillion-dollar verdicts, has been raised considerably.

There are two coordinated actions filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775, presided by Honorable William Highberger) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, Case No. 100300296).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!